1702.HK
Dongguang Chemical Limited [1702.HK] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
1702.HK Stock Summary
In the News
1702.HK Financial details
Company Rating
Buy
Market Cap
1.24B
Income
117.26M
Revenue
3.03B
Book val./share
2.65
Cash/share
1
Dividend
0.08
Dividend %
3.8%
Employees
1.29K
Optionable
No
Shortable
Yes
Earnings
22 Mar 2024
P/E
6.73
Forward P/E
-
PEG
-1.2
P/S
0.42
P/B
0.81
P/C
2.06
P/FCF
5.01
Quick Ratio
2.52
Current Ratio
3.83
Debt / Equity
0.02
LT Debt / Equity
0.02
-
-
EPS (TTM)
0.19
EPS next Y
-
EPS next Q
-
EPS this Y
-27.91%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
14.14%
Revenue last 5Y
6.5%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
10%
ROE
13%
ROC
0.17%
Gross Margin
11%
Oper. Margin
9%
Profit Margin
6%
Payout
26%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.5-2.95
52W High
+3%
52W Low
+106%
RSI
50.52
Rel Volume
4
Avg Volume
1000
Volume
4K
Perf Week
-10.43%
Perf Month
-
Perf Quarter
-
Perf Half Y
4.57%
-
-
-
-
Beta
0.407
-
-
Volatility
0.2%, 0.17%
Prev Close
-5.5%
Price
2.06
Change
37.33%
1702.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 3.69 | 3.42 | 3.15 | 4.64 | 5.04 | |
| Net income per share | 0.16 | 0.26 | 0.2 | 0.43 | 0.31 | |
| Operating cash flow per share | 0.75 | 0.67 | 0.5 | 0.56 | 0.49 | |
| Free cash flow per share | 0.58 | 0.53 | 0.22 | 0.44 | 0.42 | |
| Cash per share | 0.35 | 0.7 | 0.59 | 0.68 | 0.86 | |
| Book value per share | 1.61 | 1.84 | 1.98 | 2.36 | 2.59 | |
| Tangible book value per share | 1.47 | 1.85 | 1.99 | 2.38 | 2.61 | |
| Share holders equity per share | 1.61 | 1.84 | 1.98 | 2.36 | 2.59 | |
| Interest debt per share | 1.06 | 0.81 | 0.54 | 0.23 | 0.05 | |
| Market cap | 1.52B | 1.33B | 1.05B | 1.26B | 1.44B | |
| Enterprise value | 1.91B | 1.37B | 997.34M | 956.05M | 929.59M | |
| P/E ratio | 15.29 | 8.23 | 8.34 | 4.72 | 7.39 | |
| Price to sales ratio | 0.67 | 0.63 | 0.53 | 0.44 | 0.46 | |
| POCF ratio | 3.28 | 3.18 | 3.34 | 3.59 | 4.69 | |
| PFCF ratio | 4.25 | 4.04 | 7.74 | 4.63 | 5.5 | |
| P/B Ratio | 1.53 | 1.16 | 0.85 | 0.86 | 0.89 | |
| PTB ratio | 1.53 | 1.16 | 0.85 | 0.86 | 0.89 | |
| EV to sales | 0.84 | 0.65 | 0.51 | 0.33 | 0.3 | |
| Enterprise value over EBITDA | 5.15 | 3.35 | 2.89 | 1.69 | 2.26 | |
| EV to operating cash flow | 4.12 | 3.27 | 3.19 | 2.73 | 3.04 | |
| EV to free cash flow | 5.33 | 4.16 | 7.39 | 3.52 | 3.56 | |
| Earnings yield | 0.07 | 0.12 | 0.12 | 0.21 | 0.14 | |
| Free cash flow yield | 0.24 | 0.25 | 0.13 | 0.22 | 0.18 | |
| Debt to equity | 0.6 | 0.41 | 0.26 | 0.08 | 0.02 | |
| Debt to assets | 0.33 | 0.26 | 0.18 | 0.07 | 0.02 | |
| Net debt to EBITDA | 1.04 | 0.09 | -0.14 | -0.53 | -1.23 | |
| Current ratio | 0.72 | 0.92 | 1.06 | 2.15 | 3.83 | |
| Interest coverage | 4.08 | 7.59 | 10.54 | 23.17 | 141.34 | |
| Income quality | 2.8 | 1.9 | 1.82 | 0.91 | 1.11 | |
| Dividend Yield | 0.01 | 0.02 | 0.03 | 0.02 | 0.04 | |
| Payout ratio | 0.11 | 0.13 | 0.27 | 0.1 | 0.26 | |
| Sales general and administrative to revenue | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.05 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | -0.23 | -0.21 | -0.57 | -0.22 | -0.15 | |
| Capex to revenue | -0.05 | -0.04 | -0.09 | -0.03 | -0.01 | |
| Capex to depreciation | -0.7 | -0.58 | -1.09 | -0.48 | -0.34 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 2.41 | 3.28 | 3 | 4.77 | 4.27 | |
| ROIC | 0.08 | 0.11 | 0.09 | 0.18 | 0.12 | |
| Return on tangible assets | 0.06 | 0.09 | 0.07 | 0.14 | 0.1 | |
| Graham Net | -0.92 | -0.33 | -0.18 | 0.24 | 0.58 | |
| Working capital | -196.79M | -49.95M | 28.47M | 369.76M | 600.05M | |
| Tangible asset value | 914.65M | 1.15B | 1.23B | 1.48B | 1.62B | |
| Net current asset value | -320.91M | -89.01M | -16.91M | 330.83M | 563.46M | |
| Invested capital | 0.6 | 0.41 | 0.26 | 0.08 | 0.02 | |
| Average receivables | 0 | 94K | 4.34M | 13.17M | 13.81M | |
| Average payables | 48.49M | 66.92M | 70.14M | 58.65M | 52.22M | |
| Average inventory | 84.78M | 86.93M | 81.66M | 110.83M | 134.28M | |
| Days sales outstanding | 0 | 0.03 | 1.58 | 2.26 | 1.14 | |
| Days payables outstanding | 10.34 | 15.63 | 13.34 | 8.19 | 6.52 | |
| Days of inventory on hand | 17.02 | 16.35 | 17.48 | 20.98 | 16.85 | |
| Receivables turnover | 0 | 11.29K | 230.37 | 161.48 | 319.99 | |
| Payables turnover | 35.29 | 23.35 | 27.36 | 44.54 | 55.95 | |
| Inventory turnover | 21.44 | 22.33 | 20.89 | 17.39 | 21.66 | |
| ROE | 0.1 | 0.14 | 0.1 | 0.18 | 0.12 | |
| Capex per share | -0.17 | -0.14 | -0.29 | -0.13 | -0.07 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
| Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 1.38 | 1.14 | 1.14 | 1.3 | 1.3 | |
| Net income per share | 0.12 | 0.04 | 0.04 | 0.06 | 0.06 | |
| Operating cash flow per share | 0.17 | 0.07 | 0.07 | 0.14 | 0.14 | |
| Free cash flow per share | 0.15 | 0.06 | 0.06 | 0.1 | 0.1 | |
| Cash per share | 0.74 | 0.86 | 0.86 | 1 | 1 | |
| Book value per share | 2.52 | 2.59 | 2.59 | 2.65 | 2.65 | |
| Tangible book value per share | 2.54 | 2.61 | 2.61 | 2.66 | 2.66 | |
| Share holders equity per share | 2.52 | 2.59 | 2.59 | 2.65 | 2.65 | |
| Interest debt per share | 0.05 | 0 | 0.05 | 0 | 0.05 | |
| Market cap | 1.35B | 1.29B | 1.44B | 1.52B | 1.67B | |
| Enterprise value | 916.43M | 758.97M | 929.62M | 896.01M | 1.08B | |
| P/E ratio | 4.55 | 13.92 | 15.45 | 10.74 | 11.8 | |
| Price to sales ratio | 1.57 | 1.84 | 2.04 | 1.88 | 2.06 | |
| POCF ratio | 12.55 | 28.42 | 31.55 | 18.08 | 19.86 | |
| PFCF ratio | 14.65 | 32.22 | 35.77 | 24.19 | 26.58 | |
| P/B Ratio | 0.86 | 0.8 | 0.89 | 0.92 | 1.02 | |
| PTB ratio | 0.86 | 0.8 | 0.89 | 0.92 | 1.02 | |
| EV to sales | 1.07 | 1.08 | 1.32 | 1.11 | 1.33 | |
| Enterprise value over EBITDA | 6.42 | 12.74 | 15.61 | 11.02 | 13.22 | |
| EV to operating cash flow | 8.53 | 16.67 | 20.41 | 10.66 | 12.78 | |
| EV to free cash flow | 9.97 | 18.89 | 23.14 | 14.26 | 17.11 | |
| Earnings yield | 0.05 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Free cash flow yield | 0.07 | 0.03 | 0.03 | 0.04 | 0.04 | |
| Debt to equity | 0.02 | 0 | 0.02 | 0 | 0.02 | |
| Debt to assets | 0.02 | 0 | 0.02 | 0 | 0.02 | |
| Net debt to EBITDA | -3.02 | -8.99 | -8.52 | -7.67 | -7.32 | |
| Current ratio | 3.46 | 3.83 | 3.83 | 4.7 | 4.7 | |
| Interest coverage | 0 | 0 | 24.57 | 0 | 44 | |
| Income quality | 1.45 | 1.96 | 1.96 | 2.38 | 2.38 | |
| Dividend Yield | 0.02 | 0 | 0 | 0.01 | 0.01 | |
| Payout ratio | 0.35 | 0 | 0.19 | 0.62 | 0.62 | |
| Sales general and administrative to revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | -0.14 | -0.12 | -0.12 | -0.25 | -0.25 | |
| Capex to revenue | -0.02 | -0.01 | -0.01 | -0.03 | -0.03 | |
| Capex to depreciation | -0.45 | -0.16 | -0.16 | -0.64 | -0.64 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 2.6 | 1.48 | 1.48 | 1.84 | 1.84 | |
| ROIC | 0.05 | 0.01 | 0.01 | 0.02 | 0.02 | |
| Return on tangible assets | 0.04 | 0.01 | 0.01 | 0.02 | 0.02 | |
| Graham Net | 0.46 | 0.64 | 0.58 | 0.77 | 0.72 | |
| Working capital | 501.76M | 600.05M | 600.05M | 654.97M | 654.97M | |
| Tangible asset value | 1.58B | 1.62B | 1.62B | 1.65B | 1.65B | |
| Net current asset value | 463.91M | 563.46M | 563.46M | 619.98M | 619.98M | |
| Invested capital | 0.02 | 0 | 0.02 | 0 | 0.02 | |
| Average receivables | 0 | 12M | 9.78M | 9.29M | 8.79M | |
| Average payables | 0 | 48.94M | 50.06M | 45M | 39.94M | |
| Average inventory | 0 | 160.07M | 166.57M | 124.35M | 87.28M | |
| Days sales outstanding | 1.49 | 1.25 | 1.25 | 0.98 | 0.98 | |
| Days payables outstanding | 5.86 | 6.77 | 6.77 | 4.81 | 4.81 | |
| Days of inventory on hand | 14.24 | 27.56 | 17.48 | 14.37 | 6.64 | |
| Receivables turnover | 60.53 | 72.08 | 72.08 | 92.12 | 92.12 | |
| Payables turnover | 15.37 | 13.3 | 13.3 | 18.72 | 18.72 | |
| Inventory turnover | 6.32 | 3.27 | 5.15 | 6.26 | 13.55 | |
| ROE | 0.05 | 0.01 | 0.01 | 0.02 | 0.02 | |
| Capex per share | -0.02 | -0.01 | -0.01 | -0.03 | -0.03 |
1702.HK Frequently Asked Questions
What is Dongguang Chemical Limited stock symbol ?
Dongguang Chemical Limited is a CN stock and trading under the symbol 1702.HK
What is Dongguang Chemical Limited stock quote today ?
Dongguang Chemical Limited stock price is $2.06 today.
Is Dongguang Chemical Limited stock public?
Yes, Dongguang Chemical Limited is a publicly traded company.
Company Profile
- Volume Average 1000
- Market Capitalization 1.24B
- Employee 1.29K
- CEO Mr. Zhihe Wang
- Headquarters Cangzhou,CN
- IPO Date 2017-07-12
-
Website
https://www.dg-chemical.com 
Dongguang Chemical Limited, an investment holding company, manufactures and sells urea in the People's Republic of China. It offers coal-based urea for use as a source of nitrogen in fertilizers and industrial applications, such as production of adhesives, coatings, plastics, and cosmetics; and urea by-products, including methanol, liquid carbon dioxide, and liquefied natural gas. The company was formerly known as Sino-coal Chemical Limited and changed its name to Dongguang Chemical Limited in June 2015. Dongguang Chemical Limited was founded in 1970 and is headquartered in Cangzhou, the People's Republic of China.
